These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ecklonia cava Polyphenol Has a Protective Effect against Ethanol-Induced Liver Injury in a Cyclic AMP-Dependent Manner. Yamashita H; Goto M; Matsui-Yuasa I; Kojima-Yuasa A Mar Drugs; 2015 Jun; 13(6):3877-91. PubMed ID: 26096275 [TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Kwon HJ; Won YS; Park O; Chang B; Duryee MJ; Thiele GE; Matsumoto A; Singh S; Abdelmegeed MA; Song BJ; Kawamoto T; Vasiliou V; Thiele GM; Gao B Hepatology; 2014 Jul; 60(1):146-57. PubMed ID: 24492981 [TBL] [Abstract][Full Text] [Related]
10. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease. Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911 [TBL] [Abstract][Full Text] [Related]
11. Effect of liver disorders on ethanol elimination and alcohol and aldehyde dehydrogenase activities in liver and erythrocytes. Zorzano A; Ruiz del Arbol L; Herrera E Clin Sci (Lond); 1989 Jan; 76(1):51-7. PubMed ID: 2920534 [TBL] [Abstract][Full Text] [Related]
12. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553 [TBL] [Abstract][Full Text] [Related]
14. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Morgan K; French SW; Morgan TR Hepatology; 2002 Jul; 36(1):122-34. PubMed ID: 12085356 [TBL] [Abstract][Full Text] [Related]
15. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Lu Y; Wu D; Wang X; Ward SC; Cederbaum AI Free Radic Biol Med; 2010 Nov; 49(9):1406-16. PubMed ID: 20692331 [TBL] [Abstract][Full Text] [Related]
16. Effect of Clomethiazole Vs. Clorazepate on Hepatic Fat and Serum Transaminase Activities in Alcohol-Associated Liver Disease: Results from a Randomized, Controlled Phase II Clinical Trial. Hohmann N; Schröder F; Moreira B; Teng H; Burhenne J; Bruckner T; Mueller S; Haefeli WE; Seitz HK Alcohol Alcohol; 2023 Mar; 58(2):134-141. PubMed ID: 36562601 [TBL] [Abstract][Full Text] [Related]
17. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis. Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961 [TBL] [Abstract][Full Text] [Related]
19. Chronic free-choice drinking in crossed high alcohol preferring mice leads to sustained blood ethanol levels and metabolic tolerance without evidence of liver damage. Matson L; Liangpunsakul S; Crabb D; Buckingham A; Ross RA; Halcomb M; Grahame N Alcohol Clin Exp Res; 2013 Feb; 37(2):194-201. PubMed ID: 22757960 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway. Ishida K; Kaji K; Sato S; Ogawa H; Takagi H; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H J Nutr Biochem; 2021 Mar; 89():108573. PubMed ID: 33388347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]